Apollo Hospitals has partnered with Singapore-based organization ConnectedLife to avail an artificial intelligence (AI) tool to predict the risk of cardiovascular diseases. This new advancement will allow doctors to intervene early in treatment by predicting the disease risk.
The Singaporean organization ConnectedLife provides digital solutions for condition management, wellness, and other health-focused applications. Under this tie-up, ConnectedLife will use the information from the Apollo Hospitals’ database to arrive at a risk score of cardiovascular diseases for its patients.
According to ConnectedLife’s founder Daryl Arnold, the data from the hospitals would be secure, and the company would adhere to the standards set by the Singapore government. He added that the data would help physicians develop a personal care plan to provide preventive care and digitally monitor the patients proactively.
Read More: AI Tool Allows Clinicians To Make Personalized Chemotherapy Doses For Cancer Patients
The joint managing director of the Apollo Hospitals group, Sangita Reddy, said that the collaboration with ConnectedLife amalgamates artificial intelligence and machine learning technology with reliable and easy-to-use risk prediction tools that provide indications for early action. She added that the partnership would boost research to understand health risk scores and that Apollo would soon expand the collaboration to other non-communicable diseases.
ConnectedLife captures and analyses patient-reported data from wearable devices like Fitbit using AI to provide patient health and wellness insights. The data is then shared with the health care providers to help them to develop a care plan. The technology offers near real-time information, including details such as exercise, sedentary time, heart rate, breathing rate, and sleep, among others.
According to the director of Fitbit Health Solutions International, Steve Morley, the program provides patients with a better view of their health metrics to help them better manage their cardiovascular health.